相关实验视频
Updated: May 5, 2026

13:42
A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
Published on: July 17, 2012
28.5K
溶性补充受体-1保护心脏,肺和心脏肌纤维功能免受心肺旁路损伤
P J Chai1, R Nassar, A E Oakeley
1Department of Surgery, Duke University, Durham, NC, USA.
Circulation
|February 9, 2000
概括
在新生猪中,溶性补充受体-1 (sCR1) 治疗改善了心脏功能,并在心肺旁路术 (CPB) 后降低了肺血管抵抗力. 这表明补充剂激活有助于CPB诱导的损伤.
科学领域:
- 心血管外科心血管外科
- 免疫学 免疫学 免疫学
- 新生儿生理学 新生儿生理学
背景情况:
- 心肺绕道 (CPB) 激活宿主防御系统,可能导致不良影响.
- 补充激活在CPB诱导的病理生理学中的作用尚未完全理解.
研究的目的:
- 研究使用可溶性补体受体-1 (sCR1) 的补体抑制对后CPB综合征的影响.
- 测试补充激活导致CPB相关并发症的假设.
主要方法:
- 20只新生猪被随机分配到对照组和sCR1治疗组.
- 血液动力学参数 (肺动脉压力/体积,心房压力,肺动脉压力/流量) 和呼吸功能 (符合性,抵抗性) 被测量.
- 计算了关键的功能指标,包括预加载可招募的中风工作,放松时间常数 (tau) 和肺血管阻力.
主要成果:
- sCR1治疗显著增加了预加载可招募的中风工作和CPB后的动脉PO2.
- sCR1显著降低了异体体透性放松时间常数 (tau) 和肺血管阻力.
- 在sCR1组中,心房肌动脉的希尔系数显著更高,表明收缩能力有所改善.
结论:
- 溶性补充受体-1 (sCR1) 有效地缓和了后CPB综合征.
- 这些发现支持了补充激活在CPB诱导的病理生理学中起着重要作用的假设.
相关概念视频
Complement System
10.6K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952

